{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:50:56Z","timestamp":1792698656690,"version":"4.5.0"},"reference-count":132,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jchf.2026.102943","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T04:25:25Z","timestamp":1772857525000},"page":"102943","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Kidney Disease and Heart Failure: Recent Advances and Current Challenges"],"prefix":"10.1016","volume":"14","author":[{"given":"Carolyn S.P.","family":"Lam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biykem","family":"Bozkurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Z.I.","family":"Cherney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin A.","family":"Ezekowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meg J.","family":"Jardine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadiya S.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Madero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Sarnak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozine M.","family":"ter Maaten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6233-2831","authenticated-orcid":false,"given":"Michael","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan E.","family":"Grams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7369-7812","authenticated-orcid":false,"given":"Michel","family":"Jadoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9583-8628","authenticated-orcid":false,"given":"Nisha","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy M.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Awdishu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bains","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debasish","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita","family":"Bavanandan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saul","family":"Blecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher T.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Coresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"D\u00e9pret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Fukagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Pedro","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan G.","family":"Howlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeera","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Ma\u0142yszko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick B.","family":"Mark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Mentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendon L.","family":"Neuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies","family":"Ostermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambarish","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janani","family":"Rangaswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani","family":"Renouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Seliger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria F.","family":"Slon Roblero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish M.","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Teerlink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Testani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine R.","family":"Tuttle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manvir","family":"Victor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl P.","family":"Walther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Wiecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang C.","family":"Winkelmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2026.102943_bib1","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.102943_bib2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/dom.14916","article-title":"Chronic kidney disease begets heart failure and vice versa: temporal associations between heart failure events in relation to incident chronic kidney disease in type 2 diabetes","volume":"25","author":"Wu","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jchf.2026.102943_bib3","doi-asserted-by":"crossref","first-page":"6105","DOI":"10.3390\/jcm12186105","article-title":"Heart failure in patients with chronic kidney disease","volume":"12","author":"Xanthopoulos","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jchf.2026.102943_bib4","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.jacc.2005.11.084","article-title":"Renal impairment and outcomes in heart failure: systematic review and meta-analysis","volume":"47","author":"Smith","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.102943_bib5","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.105.580506","article-title":"Renal function as a predictor of outcome in a broad spectrum of patients with heart failure","volume":"113","author":"Hillege","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.102943_bib6","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/ejhf.821","article-title":"Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction","volume":"19","author":"L\u00f6fman","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib7","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1253\/circj.72.1152","article-title":"Decreased renal function as an independent predictor of re-hospitalization for congestive heart failure","volume":"72","author":"Komukai","year":"2008","journal-title":"Circ J"},{"key":"10.1016\/j.jchf.2026.102943_bib8","article-title":"Decreased renal function is associated with heart failure readmissions","volume":"10","author":"Vindhyal","year":"2018","journal-title":"Cureus"},{"key":"10.1016\/j.jchf.2026.102943_bib9","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1016\/j.jacc.2019.02.071","article-title":"Burden and outcomes of heart failure hospitalizations in adults with chronic kidney disease","volume":"73","author":"Bansal","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.102943_bib10","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1136\/heartjnl-2021-319605","article-title":"Heart failure with preserved ejection fraction: recent concepts in diagnosis, mechanisms and management","volume":"108","author":"Gevaert","year":"2022","journal-title":"Heart"},{"key":"10.1016\/j.jchf.2026.102943_bib11","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.jacc.2023.01.049","article-title":"Heart failure with preserved ejection fraction: JACC Scientific Statement","volume":"81","author":"Borlaug","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.102943_bib12","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/CIRCULATIONAHA.117.028814","article-title":"Cardiorenal syndrome revisited","volume":"138","author":"Zannad","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.102943_bib13","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ejhf.497","article-title":"Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation","volume":"18","author":"ter Maaten","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1001\/jamacardio.2020.4511","article-title":"Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis","volume":"6","author":"McGuire","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2026.102943_bib15","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1093\/cvr\/cvad096","article-title":"Cardiorenal interactions in heart failure\u2014insights from recent therapeutic advances","volume":"120","author":"Damman","year":"2024","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jchf.2026.102943_bib16","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/S0140-6736(22)02074-8","article-title":"SGLT2 inhibitor Meta-Analysis Cardio-Renal Trialists\u2019 Consortium. Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials","volume":"400","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2026.102943_bib17","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.102943_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2213-8587(24)00271-7","article-title":"Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials","volume":"13","author":"Badve","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jchf.2026.102943_bib19","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/eurheartj\/ehab777","article-title":"Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis","volume":"43","author":"Agarwal","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2026.102943_bib20","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.jacc.2024.08.034","article-title":"Why has it been challenging to modify kidney disease progression in patients with heart failure?","volume":"84","author":"Vaduganathan","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.102943_bib21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/eht386","article-title":"Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis","volume":"35","author":"Damman","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2026.102943_bib22","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrneph.2016.113","article-title":"Heart failure and kidney dysfunction: epidemiology, mechanisms and management","volume":"12","author":"Schefold","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jchf.2026.102943_bib23","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/eurheartj\/eht066","article-title":"Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND","volume":"34","author":"Brouwers","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2026.102943_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/jamacardio.2017.4987","article-title":"Association of cardiovascular biomarkers with incident heart failure with preserved and reduced ejection fraction","volume":"3","author":"de Boer","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2026.102943_bib25","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jchf.2019.01.016","article-title":"Association of urine albumin excretion with incident heart failure hospitalization in community-dwelling adults","volume":"7","author":"Bailey","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jacc.2022.10.028","article-title":"Albuminuria and heart failure: JACC State-of-the-Art Review","volume":"81","author":"Khan","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.102943_bib27","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/jamacardio.2022.2924","article-title":"Association of empagliflozin treatment with albuminuria levels in patients with heart failure: a secondary analysis of EMPEROR-Pooled","volume":"7","author":"Ferreira","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2026.102943_bib28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.cardfail.2016.09.006","article-title":"Progression of renal impairment and chronic kidney disease in chronic heart failure: an analysis from GISSI-HF","volume":"23","author":"Damman","year":"2017","journal-title":"J Card Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib29","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.102943_bib30","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.102943_bib31","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.011173","article-title":"Risk factors and outcomes associated with heart failure with preserved and reduced ejection fraction in people with chronic kidney disease","volume":"17","author":"Bansal","year":"2024","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib32","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.amjcard.2019.07.065","article-title":"Incidence of, associations with and prognostic impact of worsening renal function in heart failure with different ejection fraction categories","volume":"124","author":"L\u00f6fman","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2026.102943_bib33","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2215\/CJN.0000000000000064","article-title":"Cardiorenal syndrome in the hospital","volume":"18","author":"McCallum","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jchf.2026.102943_bib34","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/eurjhf\/hfs209","article-title":"Determinants of dynamic changes in serum creatinine in acute decompensated heart failure: the importance of blood pressure reduction during treatment","volume":"15","author":"Dupont","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib35","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(88)91851-X","article-title":"Raised venous pressure: a direct cause of renal sodium retention in oedema?","volume":"1","author":"Firth","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2026.102943_bib36","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacc.2008.02.083","article-title":"Sodium nitroprusside for advanced low-output heart failure","volume":"52","author":"Mullens","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.102943_bib37","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.amjcard.2010.07.050","article-title":"Characteristics of patients with improvement or worsening in renal function during treatment of acute decompensated heart failure","volume":"106","author":"Testani","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2026.102943_bib38","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s00380-020-01634-9","article-title":"Intra-abdominal pressure and its relationship with markers of congestion in patients admitted for acute decompensated heart failure","volume":"35","author":"Rubio-Gracia","year":"2020","journal-title":"Heart Vessels"},{"key":"10.1016\/j.jchf.2026.102943_bib39","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ejheart.2007.05.010","article-title":"Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction","volume":"9","author":"Damman","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib40","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.jacc.2016.03.537","article-title":"Cardiac output and renal dysfunction: definitely more than impaired flow","volume":"67","author":"Mullens","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.102943_bib41","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2215\/CJN.03720321","article-title":"Assessment of proximal tubular function by tubular maximum phosphate reabsorption capacity in heart failure","volume":"17","author":"Emmens","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jchf.2026.102943_bib42","article-title":"Renal biomarkers in heart failure: systematic review and meta-analysis","volume":"3","author":"Kumar","year":"2024","journal-title":"JACC Adv"},{"key":"10.1016\/j.jchf.2026.102943_bib43","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/eurheartj\/ehr190","article-title":"Clinical outcome of renal tubular damage in chronic heart failure","volume":"32","author":"Damman","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2026.102943_bib44","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jchf.2013.05.007","article-title":"Tubular damage and worsening renal function in chronic heart failure","volume":"1","author":"Damman","year":"2013","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib45","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1136\/hrt.2010.194878","article-title":"Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate","volume":"96","author":"Damman","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.jchf.2026.102943_bib46","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1161\/CIRCULATIONAHA.117.030112","article-title":"Worsening renal function in patients with acute heart failure undergoing aggressive diuresis is not associated with tubular injury","volume":"137","author":"Ahmad","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.102943_bib47","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.009776","article-title":"Improvement in renal function during the treatment of acute decompensated heart failure: relationship with markers of renal tubular injury and prognostic importance","volume":"16","author":"Natov","year":"2023","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib48","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0140-6736(09)61378-7","article-title":"Albuminuria in chronic heart failure: prevalence and prognostic importance","volume":"374","author":"Jackson","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2026.102943_bib49","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/eurheartj\/ehac528","article-title":"Albuminuria as a marker of systemic congestion in patients with heart failure","volume":"44","author":"Boorsma","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2026.102943_bib50","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/CIRCHEARTFAILURE.109.881805","article-title":"Prevalence and prognostic value of elevated urinary albumin excretion in patients with chronic heart failure: data from the GISSI-Heart Failure trial","volume":"3","author":"Masson","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib51","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1007\/s00380-022-02025-y","article-title":"Urine albumin-to-creatinine ratio on admission predicts early rehospitalization in patients with acute decompensated heart failure","volume":"37","author":"Matsumoto","year":"2022","journal-title":"Heart Vessels"},{"key":"10.1016\/j.jchf.2026.102943_bib52","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/01.CIR.0000139860.33974.28","article-title":"Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy","volume":"110","author":"de Zeeuw","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.102943_bib53","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/ejhf.778","article-title":"The association of chronic kidney disease and microalbuminuria with heart failure with preserved vs. reduced ejection fraction","volume":"19","author":"Nayor","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib54","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.jacc.2007.12.048","article-title":"Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study","volume":"51","author":"Bahrami","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.102943_bib55","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1681\/ASN.2014040408","article-title":"Urinary angiotensinogen level predicts AKI in acute decompensated heart failure: a prospective, two-stage study","volume":"26","author":"Yang","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jchf.2026.102943_bib56","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.2337\/dc21-0723","article-title":"Chronic kidney disease testing among at-risk adults in the U.S. remains low: real-world evidence from a national laboratory database","volume":"44","author":"Alfego","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jchf.2026.102943_bib57","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/ejhf.462","article-title":"Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction","volume":"18","author":"Damman","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib58","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ahj.2015.05.003","article-title":"Diuretic response in acute heart failure-an analysis from ASCEND-HF","volume":"170","author":"ter Maaten","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2026.102943_bib59","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.102943_bib60","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/CIRCULATIONAHA.109.933275","article-title":"Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival","volume":"122","author":"Testani","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.102943_bib61","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1161\/CIRCHEARTFAILURE.112.968230","article-title":"Blood urea nitrogen\/creatinine ratio identifies a high-risk but potentially reversible form of renal dysfunction in patients with decompensated heart failure","volume":"6","author":"Brisco","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib62","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/eurjhf\/hfr123","article-title":"Influence of renal dysfunction phenotype on mortality in the setting of cardiac dysfunction: analysis of three randomized controlled trials","volume":"13","author":"Testani","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib63","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/eurjhf\/hfs039","article-title":"Lack of significant renal tubular injury despite acute kidney injury in acute decompensated heart failure","volume":"14","author":"Dupont","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib64","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jchf.2024.09.013","article-title":"Decongestion and outcomes in patients hospitalized for acute heart failure: insights from the RELAX-AHF-2 Trial","volume":"13","author":"Pagnesi","year":"2025","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib65","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijcard.2018.01.067","article-title":"Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure","volume":"258","author":"Rubio-Gracia","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jchf.2026.102943_bib66","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cardfail.2021.01.022","volume":"27","author":"Bozkurt","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib67","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.jacc.2021.12.011","article-title":"2022 AHA\/ACC\/HFSA Guideline for the management of heart failure: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.102943_bib68","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.amjcard.2012.05.014","article-title":"Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction","volume":"110","author":"Anjan","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2026.102943_bib69","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1161\/CIRCHEARTFAILURE.111.963256","article-title":"Prognostic importance of early worsening renal function after initiation of angiotensin-converting enzyme inhibitor therapy in patients with cardiac dysfunction","volume":"4","author":"Testani","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib70","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.102943_bib71","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jchf.2018.02.004","article-title":"Renal effects and associated outcomes during angiotensin-neprilysin inhibition in heart failure","volume":"6","author":"Damman","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib72","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1053\/j.ajkd.2021.06.017","article-title":"Upper reference limits for high-sensitivity cardiac troponin T and N-terminal fragment of the prohormone brain natriuretic peptide in patients with CKD","volume":"79","author":"Bansal","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jchf.2026.102943_bib73","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/CIRCULATIONAHA.123.066377","article-title":"Variation of NT-proBNP and high-sensitivity cardiac troponin T across levels of estimated glomerular filtration rate: the SPRINT trial","volume":"149","author":"Bansal","year":"2024","journal-title":"Circulation"},{"issue":"4S","key":"10.1016\/j.jchf.2026.102943_bib74","first-page":"S117","article-title":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.jchf.2026.102943_bib75","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jchf.2022.06.001","article-title":"It is time to screen for heart failure: why and how?","volume":"10","author":"Bozkurt","year":"2022","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib76","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and validation of the American Heart Association\u2019s PREVENT equations","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation"},{"issue":"5S","key":"10.1016\/j.jchf.2026.102943_bib77","first-page":"S1","article-title":"KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease","volume":"102","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.jchf.2026.102943_bib78","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2026.102943_bib79","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2026.102943_bib80","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jacc.2023.12.024","article-title":"2024 ACC expert consensus decision pathway for treatment of heart failure with reduced ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"83","author":"Maddox","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.102943_bib81","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jchf.2019.02.009","article-title":"Medical management of heart failure with reduced ejection fraction in patients with advanced renal disease","volume":"7","author":"Hein","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib82","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.102943_bib83","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1161\/CIRCULATIONAHA.121.052792","article-title":"Evidence-based medical therapy in patients with heart failure with reduced ejection fraction and chronic kidney disease","volume":"145","author":"Beldhuis","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.102943_bib84","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDccon2200084","article-title":"How do I optimize heart failure medications for patients with hypotension or chronic kidney disease?","volume":"1","author":"Gilstrap","year":"2022","journal-title":"NEJM Evid"},{"key":"10.1016\/j.jchf.2026.102943_bib85","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.jacc.2023.03.393","article-title":"2023 ACC expert consensus decision pathway on management of heart failure with preserved ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"81","author":"Kittleson","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.102943_bib86","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMoa2407107","article-title":"Finerenone in heart failure with mildly reduced or preserved ejection fraction","volume":"391","author":"Solomon","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.102943_bib87","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.cardfail.2024.04.015","article-title":"Generalizability of the spectrum of kidney risk in the FINEARTS-HF trial to U.S. adults with heart failure","volume":"30","author":"Ostrominski","year":"2024","journal-title":"J Card Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib88","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.102943_bib89","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jchf.2020.03.009","article-title":"Acute kidney function declines in the context of decongestion in acute decompensated heart failure","volume":"8","author":"McCallum","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib90","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.amjmed.2019.05.047","article-title":"Relation of kidney function decline and NT-proBNP with risk of mortality and readmission in acute decompensated heart failure","volume":"133","author":"McCallum","year":"2020","journal-title":"Am J Med"},{"key":"10.1016\/j.jchf.2026.102943_bib91","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1161\/CIRCULATIONAHA.121.058910","article-title":"Initial decline (dip) in estimated glomerular filtration rate after initiation of dapagliflozin in patients with heart failure and reduced ejection fraction: insights from DAPA-HF","volume":"146","author":"Adamson","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.102943_bib92","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/ejhf.3074","article-title":"Early changes in renal function during rapid up-titration of guideline-directed medical therapy following an admission for acute heart failure","volume":"25","author":"ter Maaten","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib93","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/ejhf.2471","article-title":"Renal effects of guideline-directed medical therapies in heart failure: a consensus document from the Heart Failure Association of the European Society of Cardiology","volume":"24","author":"Mullens","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib94","first-page":"1","article-title":"KDIGO Clinical Practice Guideline for Acute Kidney Injury","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.jchf.2026.102943_bib95","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ejhf.2384","article-title":"Worsening renal function in acute heart failure in the context of diuretic response","volume":"24","author":"Emmens","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib96","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/CIRCHEARTFAILURE.111.963413","article-title":"Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function","volume":"5","author":"Metra","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib97","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/ehf2.14310","article-title":"Intravenous iron infusion in patients with heart failure: a systematic review and study-level meta-analysis","volume":"10","author":"Salah","year":"2023","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib98","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1016\/j.jacc.2024.03.431","article-title":"Intravenous iron repletion for patients with heart failure and iron deficiency: JACC State-of-the-Art Review","volume":"83","author":"Cheema","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.102943_bib99","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1001\/jama.2025.3833","article-title":"Intravenous ferric carboxymaltose in heart failure with iron deficiency: the FAIR-HF2 DZHK05 randomized clinical trial","volume":"333","author":"Anker","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2026.102943_bib100","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa2304968","article-title":"Ferric carboxymaltose in heart failure with iron deficiency","volume":"389","author":"Mentz","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.102943_bib101","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/ejhf.2270","article-title":"Ferric carboxymaltose for the treatment of iron deficiency in heart failure: a multinational cost-effectiveness analysis utilising AFFIRM-AHF","volume":"23","author":"McEwan","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib102","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0140-6736(22)00369-5","article-title":"Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial","volume":"399","author":"Ezekowitz","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2026.102943_bib103","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.pcad.2024.01.004","article-title":"The current state of evidence for sodium and fluid restriction in heart failure","volume":"82","author":"Colin-Ramirez","year":"2024","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jchf.2026.102943_bib104","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s00392-023-02256-7","article-title":"Role of dietary sodium restriction in chronic heart failure: systematic review and meta-analysis","volume":"113","author":"Urban","year":"2024","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jchf.2026.102943_bib105","article-title":"Sodium restriction in patients with heart failure: a systematic review and meta-analysis of randomized clinical trials","volume":"16","author":"Colin-Ramirez","year":"2023","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib106","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJMoa2203094","article-title":"Acetazolamide in acute decompensated heart failure with volume overload","volume":"387","author":"Mullens","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.102943_bib107","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/eurheartj\/ehac530","article-title":"Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial","volume":"44","author":"Biegus","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2026.102943_bib108","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jacc.2019.12.059","article-title":"Diuretic therapy for patients with heart failure: JACC State-of-the-Art Review","volume":"75","author":"Felker","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.102943_bib109","doi-asserted-by":"crossref","first-page":"749","DOI":"10.34067\/KID.0000602022","article-title":"Mission and 1-year outcomes of a cardiorenal subspecialty consultation service","volume":"3","author":"Bansal","year":"2022","journal-title":"Kidney360"},{"key":"10.1016\/j.jchf.2026.102943_bib110","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002370","article-title":"Rapid and highly accurate prediction of poor loop diuretic natriuretic response in patients with heart failure","volume":"9","author":"Testani","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib111","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cardfail.2018.01.009","article-title":"Spot urine sodium as triage for effective diuretic infusion in an ambulatory heart failure unit","volume":"24","author":"Brinkley","year":"2018","journal-title":"J Card Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib112","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","article-title":"Ultrafiltration in decompensated heart failure with cardiorenal syndrome","volume":"367","author":"Bart","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.102943_bib113","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/eurheartj\/ehac689","article-title":"Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial","volume":"44","author":"Trull\u00e0s","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2026.102943_bib114","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1161\/CIRCHEARTFAILURE.114.001957","volume":"8","author":"Lala","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib115","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10741-024-10384-z","article-title":"Development of a new miniaturized system for ultrafiltration","volume":"29","author":"Ram\u00edrez-Guerrero","year":"2024","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jchf.2026.102943_bib116","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jchf.2024.08.009","article-title":"Natriuretic peptides, kidney function, and clinical outcomes in heart failure with preserved ejection fraction","volume":"13","author":"Neuen","year":"2025","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib117","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1161\/CIRCULATIONAHA.120.049514","article-title":"Challenges of cardio-kidney composite outcomes in large-scale clinical trials","volume":"143","author":"Patel","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.102943_bib118","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.kint.2020.07.013","article-title":"International consensus definitions of clinical trial outcomes for kidney failure: 2020","volume":"98","author":"Levin","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.jchf.2026.102943_bib119","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.kint.2023.03.037","article-title":"Effects of newer kidney protective agents on kidney endpoints provide implications for future clinical trials","volume":"104","author":"Heerspink","year":"2023","journal-title":"Kidney Int"},{"key":"10.1016\/j.jchf.2026.102943_bib120","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1053\/j.ajkd.2014.07.030","article-title":"GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration","volume":"64","author":"Levey","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jchf.2026.102943_bib121","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1038\/s41591-023-02418-0","article-title":"A meta-analysis of GFR slope as a surrogate endpoint for kidney failure","volume":"29","author":"Inker","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.jchf.2026.102943_bib122","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1681\/ASN.0000000000000243","article-title":"Development and validation of a new hierarchical composite end point for clinical trials of kidney disease progression","volume":"34","author":"Heerspink","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jchf.2026.102943_bib123","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1681\/ASN.0000000000000244","article-title":"Validity and utility of a hierarchical composite end point for clinical trials of kidney disease progression: a review","volume":"34","author":"Little","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jchf.2026.102943_bib124","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1681\/ASN.0000000000000117","article-title":"Change in albuminuria and GFR slope as joint surrogate end points for kidney failure: implications for phase 2 clinical trials in CKD","volume":"34","author":"Heerspink","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jchf.2026.102943_bib125","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.102943_bib126","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jchf.2014.09.008","article-title":"Heart failure therapeutics on the basis of a biased ligand of the angiotensin-2 type 1 receptor: rationale and design of the BLAST-AHF study (Biased Ligand of the Angiotensin Receptor Study in Acute Heart Failure)","volume":"3","author":"Felker","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib127","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.cardfail.2023.02.001","article-title":"Rationale, design and baseline characteristics of the PARAGLIDE-HF trial: sacubitril\/valsartan vs valsartan in HFmrEF and HFpEF with a worsening heart failure event","volume":"29","author":"Mentz","year":"2023","journal-title":"J Card Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib128","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ejhf.2027","article-title":"Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study","volume":"23","author":"Damy","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.102943_bib129","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1513\/AnnalsATS.202003-192SD","article-title":"The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study: rationale and design","volume":"17","author":"Angus","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jchf.2026.102943_bib130","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.123.010560","article-title":"Utilizing quality of life adjusted days alive and out of hospital in heart failure clinical trials","volume":"17","author":"Gouda","year":"2024","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jchf.2026.102943_bib131","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12955-021-01800-1","article-title":"Enabling patient-reported outcome measures in clinical trials, exemplified by cardiovascular trials","volume":"19","author":"Coles","year":"2021","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jchf.2026.102943_bib132","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jchf.2015.10.015","article-title":"Utility of patient-reported outcome instruments in heart failure","volume":"4","author":"Kelkar","year":"2016","journal-title":"JACC Heart Fail"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177926000417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177926000417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T23:15:04Z","timestamp":1776294904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177926000417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":132,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2213177926000417"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2026.102943","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kidney Disease and Heart Failure: Recent Advances and Current Challenges","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2026.102943","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the Kidney Disease: Improving Global Outcomes (KDIGO). Published by Elsevier Inc on behalf of the International Society of Nephrology and American College of Cardiology","name":"copyright","label":"Copyright"}],"article-number":"102943"}}